author-photo

Charlotte K. Brierley

University of Oxford

17

Papers

124

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes.

2020 Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Molecular Characterisation of Participants in the Phazar Trial Reveals Prognostic Impact of Mutations in Advanced-Phase-MPN

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Phazar: A Phase Ib Study to Assess the Safety and Tolerability of Ruxolitinib in Combination with Azacitidine in Advanced Phase Myeloproliferative Neoplasms (MPN), Including Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukaemia (AML) Arising from MPN [ISRCTN16783472]

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Impact of graft‐versus‐lymphoma effect on outcomes after reduced intensity conditioned‐alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Autologous Haematopoietic Stem Cell Transplantation for Crohn’s Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (24)
OP021 Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (4)
Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration

2017 Blood
- Charlotte K. Brierley
- Toby A. Eyre
Show All
- Source
- Cite
- Save
Citations (0)
Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?

2016 Current Opinion in Hematology
- Charlotte K. Brierley
- David P. Steensma
Show All
- Source
- Cite
- Save
Citations (14)
Outcomes and Impact of Donor Lymphocyte Infusion after Reduced Intensity Conditioned-Alemtuzumab Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Mature Lymphoid Malignancies

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT

2015 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (6)